| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2001 | CA2392703A1 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | CA2363274A1 Fused-ring compounds and use thereof as drugs for hepatitis c |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1113015A1 Optically active 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists |
| 07/04/2001 | EP1113014A1 Linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them |
| 07/04/2001 | EP1113013A1 Benzothiophene compounds, intermediates, compositions and methods |
| 07/04/2001 | EP1113011A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 07/04/2001 | EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 07/04/2001 | EP1112998A1 Amine derivatives |
| 07/04/2001 | EP1112749A2 Preventives or remedies for eye circulatory failure |
| 07/04/2001 | EP1112743A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both |
| 07/04/2001 | EP1112742A1 Remedies or preventives containing cyclopentenone compounds as the active ingredient |
| 07/04/2001 | EP1112741A1 Use of protease inhibitors for the treatment of necrotizing infections |
| 07/04/2001 | EP1112738A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 07/04/2001 | EP1112737A1 Oral pharmaceutical preparation comprising paracetamol and metoclopramide |
| 07/04/2001 | EP1112692A1 Drinks and foods capable of eliminating i helicobacter pylori /i |
| 07/04/2001 | EP1112497A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 07/04/2001 | EP1112495A2 Antibacterial disaccharide derivatives |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112356A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers |
| 07/04/2001 | EP1112284A1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/04/2001 | EP1112280A1 Method of preparing form ii crystals of clarithromycin |
| 07/04/2001 | EP1112275A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 07/04/2001 | EP1112272A1 Muscarinic agonists and antagonists |
| 07/04/2001 | EP1112271A1 Ergoline amine derivatives with blood pressure lowering effect |
| 07/04/2001 | EP1112270A1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
| 07/04/2001 | EP1112269A2 Hiv protease inhibitors |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112265A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112253A1 Branched alkyl pyrrolidine-3-carboxylic acids |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112250A1 Therapeutic compounds and methods |
| 07/04/2001 | EP1112106A2 Serotonergic 5ht2 agonists for treating glaucoma |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112089A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 07/04/2001 | EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 07/04/2001 | EP1112086A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
| 07/04/2001 | EP1112080A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 07/04/2001 | EP1112079A1 Myrtle extract, preparation method and use |
| 07/04/2001 | EP1112076A1 Polymeric compounds and methods of formulating same |
| 07/04/2001 | EP1112075A1 Compositions for the treatment of male erectile dysfunction |
| 07/04/2001 | EP1112074A1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 07/04/2001 | EP1112073A1 Calcilytic compounds |
| 07/04/2001 | EP1112072A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1112069A2 Medicament utilization and combination |
| 07/04/2001 | EP1112068A2 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| 07/04/2001 | EP1112067A2 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes |
| 07/04/2001 | EP1112066A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/04/2001 | EP1112065A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative |
| 07/04/2001 | EP1112064A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications |
| 07/04/2001 | EP1112063A1 Lipstatin derivative-soluble fiber tablets |
| 07/04/2001 | EP1112062A1 Mousse composition |
| 07/04/2001 | EP1112061A1 Drug preparations for treating sexual dysfunction |
| 07/04/2001 | EP1112057A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 07/04/2001 | EP1112053A1 Organosilicone compositions for personal care |
| 07/04/2001 | EP1112052A1 Method and device for producing tablets |
| 07/04/2001 | EP1112005A1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 07/04/2001 | EP1111995A1 Topical dermal antimicrobial compositions |
| 07/04/2001 | EP0969832B1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
| 07/04/2001 | EP0925284B1 New polycyclic phthalazin derivatives and their use |
| 07/04/2001 | EP0902777B1 D-mannitol and its preparation |
| 07/04/2001 | EP0896538B1 Use of activity inhibiting dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | EP0825980B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 07/04/2001 | EP0821689B1 Tumor protease activated prodrugs of phosphoramide mustard analogs |
| 07/04/2001 | EP0814776B1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 07/04/2001 | EP0783308B1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 07/04/2001 | EP0727983B1 Process for preparing a clodronate preparation |
| 07/04/2001 | EP0706370B1 Stable topical retinoid compositions |
| 07/04/2001 | EP0666746B1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/04/2001 | EP0579615B1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments |
| 07/04/2001 | CN1302376A Corticotropin releasing factor receptor-1 deficient mice |
| 07/04/2001 | CN1302304A AZT derivatives exhibiting spermicidal and anti-viral activity |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/04/2001 | CN1302297A Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302295A Synthetic methods for polyphenols |
| 07/04/2001 | CN1302290A Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions |
| 07/04/2001 | CN1302287A Bioreductive cytotoxic agents |
| 07/04/2001 | CN1302215A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 07/04/2001 | CN1302207A Combined therapy for bipolar disorders |
| 07/04/2001 | CN1302206A Therapeutic uses of quinoline derivatives |
| 07/04/2001 | CN1302205A Use of benzofuroxan derivatives in treating angina pectoris |
| 07/04/2001 | CN1302204A Novel fatty analogues for treatment of diabetes |
| 07/04/2001 | CN1302203A Spray-dried powders with high edible-oil loading based on non-hydrolyzed gelatin and method of making such spry-dried tablettable powders |
| 07/04/2001 | CN1302202A Opthalmic solution comprising glycogen |
| 07/04/2001 | CN1302201A Ophthalmic compositions containing galactomannan polymers and borate |
| 07/04/2001 | CN1302184A Composition for keeping away vermin |
| 07/04/2001 | CN1302183A Xylitol compositions for treating upper respiratory conditions |
| 07/04/2001 | CN1301774A Oleander flower polysaccharide and its derivatives, preparing method and use |
| 07/04/2001 | CN1301701A Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/04/2001 | CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them |